Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno

East Afr Med J. 1995 Oct;72(10):654-7.

Abstract

The cytopathicity and susceptibility of prototype HIV-1 [HTLVIIIB] and Ghanaian HIV isolates [GH1, GH2, GH3] to inhibition by ddCyd and ddIno were determined by the tetrazolium-based colorimetric method. HIV-1 [HTLVIIIB] caused the most cytopathic effect followed by HIV-2 [GH2]. At low MOI, HIV-2 [GH1] was more cytopathic than HIV-1 [GH3] but the reverse was true at high MOI. Using EC90 concentrations for comparison at similar cytopathicities, both HIV-1 [HTLVIIIB] and HIV-1 [GH3] which belong to prototype HIV-1 group, were effectively inhibited by one or both drugs. In contrast, HIV-2 [GH1] which belongs to prototype HIV-2 group, and especially, the highly divergent HIV-2 [GH2] which belongs to HIV-2b group were relatively resistant to inhibition by ddCyd and ddIno.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cytopathogenic Effect, Viral / drug effects
  • Didanosine / pharmacology*
  • Drug Evaluation, Preclinical
  • Ghana
  • HIV-1 / classification
  • HIV-1 / drug effects*
  • HIV-1 / pathogenicity*
  • HIV-2 / classification
  • HIV-2 / drug effects*
  • HIV-2 / pathogenicity*
  • Humans
  • Microbial Sensitivity Tests
  • Virus Cultivation
  • Zalcitabine / pharmacology*

Substances

  • Antiviral Agents
  • Zalcitabine
  • Didanosine